Pyrls on Instagram: Brexpiprazole's (REXULTI) new indication makes it the first FDA-approved option for agitation associated with dementia due to Alzheimer's disease ✨ Learn more about brexpiprazole in your Pyrls app or

292 likes, 1 comments - pyrls no May 14, 2023: "Brexpiprazole's (REXULTI) new indication makes it the first FDA-approved option for agitation ass"

Not Everyone Agreed With FDA Approval of Antipsychotic Rexulti for Agitation - Mad In America

FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer's Disease - US FDA

FDA fast-tracks drug for dementia agitation that increases risk of death 4 times - Study Finds

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

FDA Approves Rexulti for Agitation Associated With Dementia Due to Alzheimer's Disease

These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015

FDA Approves First Drug to Treat Dementia-Associated Agitation in AD Patients

Not Everyone Agreed With FDA Approval of Antipsychotic Rexulti for Agitation - Mad In America

Not Everyone Agreed With FDA Approval of Antipsychotic Rexulti for Agitation - Mad In America